SCHEMBL13620040

SCHEMBL13620040

NCc1cccc(CNc2ncc3[nH]c(=O)n(Cc4cc(Br)ccc4OC(F)(F)F)c3n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDR1 Q08345 3/20 0.38
PIM1 P11309 1/20 0.34
JAK2 O60674 2/20 0.34
JAK3 P52333 2/20 0.34
MCHR1 Q99705 2/20 0.34
PRKCQ Q04759 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
ADRA2A P08913 1/20 0.34
NPY5R Q15761 1/20 0.34
BRD4 O60885 1/20 0.34
USP28 Q96RU2 1/20 0.34
USP25 Q9UHP3 1/20 0.34
ABL1 P00519 1/20 0.34
USP1 O94782 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90B1 P14625 1/20 0.33
TRAP1 Q12931 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13620486 0.95 DDR1 (0.39) DDR1JAK2JAK3MCHR1TLR7
SCHEMBL13620384 0.89 DDR1 (0.39) DDR1MCHR1TLR7ADRA2ANPY5R
SCHEMBL13620047 0.88 DDR1 (0.37) DDR1MCHR1TLR7ADRA2ANPY5R
SCHEMBL13620377 0.87 DDR1 (0.41) DDR1JAK3MCHR1TLR7ADRA2A
SCHEMBL13620361 0.87 DDR1 (0.39) DDR1JAK2JAK3MCHR1ADRA2A
SCHEMBL13620058 0.86 DDR1 (0.39) DDR1JAK2JAK3MCHR1TLR7
SCHEMBL13845184 0.86 DDR1 (0.45) DDR1MCHR1ADRA2ANPY5RBRD4
SCHEMBL13620495 0.83 DDR1 (0.38) DDR1JAK2JAK3MCHR1ADRA2A
SCHEMBL13620188 0.83 MCHR1 (0.46) DDR1MCHR1PRKCQADRA2ANPY5R
SCHEMBL13620197 0.82 DDR1 (0.41) DDR1JAK2JAK3MCHR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281075-A1 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PHARMACOPEIA, INC. (US) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281075-A1 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PRKCE, PRKCZ, PRKCQ DDR1 3201/4885PIM1 596/4885JAK2 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.